P. Roy Vagelos, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 139,331 shares at $597.74 ($39.7M) on 2020-08-11, disclosed to the SEC on 2020-08-13.
Open-market sale of $39.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 73,100 | $0 | 0.0% |
| 2 | $0.00 | 341 | $0 | 0.0% |
| 3 | $594.20 | 80 | $48K | 0.1% |
| 4 | $595.69 | 162 | $97K | 0.2% |
| 5 | $595.69 | 162 | $97K | 0.2% |
| 6 | $597.74 | 950 |
| $568K |
| 1.4% |
| 7 | $598.52 | 843 | $505K | 1.3% |
| 8 | $598.52 | 843 | $505K | 1.3% |
| 9 | $599.37 | 718 | $430K | 1.1% |
| 10 | $599.37 | 718 | $430K | 1.1% |
| 11 | $600.30 | 4,851 | $2.9M | 7.3% |
| 12 | $600.30 | 4,851 | $2.9M | 7.3% |
| 13 | $601.42 | 3,281 | $2.0M | 5.0% |
| 14 | $601.42 | 3,281 | $2.0M | 5.0% |
| 15 | $602.66 | 3,769 | $2.3M | 5.7% |
| 16 | $602.66 | 3,769 | $2.3M | 5.7% |
| 17 | $603.54 | 8,622 | $5.2M | 13.1% |
| 18 | $603.54 | 8,622 | $5.2M | 13.1% |
| 19 | $604.35 | 3,171 | $1.9M | 4.8% |
| 20 | $604.35 | 3,171 | $1.9M | 4.8% |
| 21 | $605.41 | 3,331 | $2.0M | 5.1% |
| 22 | $605.41 | 3,331 | $2.0M | 5.1% |
| 23 | $606.51 | 2,684 | $1.6M | 4.1% |
| 24 | $606.51 | 2,684 | $1.6M | 4.1% |
| 25 | $607.43 | 998 | $606K | 1.5% |
| 26 | $607.43 | 998 | $606K | 1.5% |
| Total | $285.17 avg | 139,331 | $39.7M | 100% |
| Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2019-12-13 | $19.5M | — | Filing → |